COMPRESSION OF MORBIDITY: NEW INSIGHTS IN THE ROLE OF LIFESTYLE FACTORS JOHAN MACKENBACH & WILMA NUSSELDER DEPARTMENT OF PUBLIC HEALTH ERASMUS MC

Similar documents
bulletin 126 Healthy life expectancy in Australia: patterns and trends 1998 to 2012 Summary Bulletin 126 NOVEMBER 2014

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Life expectancy and healthy life expectancy in European countries

Social inequalities in all cause and cause specific mortality in a country of the African region

Master of Public Health (MPH) SC 542

The American Cancer Society Cancer Prevention Study I: 12-Year Followup

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

The increasing prevalence of overweight and obesity,

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Counting all the costs: the economic costs of comorbidities

Likelihood of Cancer

HEALTH MANAGEMENT PLAN PROGRAMME

Big Data Health Big Health Improvements? Dr Kerry Bailey MBBS BSc MSc MRCGP FFPH Dr Kelly Nock MPhys PhD

WHAT IS THE CORE RECOMMENDATION OF THE ACSM/AHA PHYSICAL ACTIVITY GUIDELINES?

on a daily basis. On the whole, however, those with heart disease are more limited in their activities, including work.

Confounding in health research

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting

How To Be A Health Care Worker

Test Your Breast Cancer Knowledge

Public Health Annual Report Statistical Compendium

Modal Age at Death: Mortality Trends in England and Wales Emily Clay

Healthy ageing and disease prevention: The case in South Africa and The Netherlands

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

Objectives. What is undernutrition? What is undernutrition? What does undernutrition look like?

Epidemiology of Hypertension 陈 奕 希 李 禾 园 王 卓

Universität Zürich. Institut für Sozial- und Präventivmedizin

Risk factors and public health in Denmark Summary report

Projecting future mortality in the Netherlands taking into account mortality delay and smoking

Number. Source: Vital Records, M CDPH

African Americans & Cardiovascular Diseases

Obesity in the United States: Public Perceptions

Health at a Glance: Europe 2014

Appendix: Description of the DIETRON model

Tips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD

THE FUTURE OF LONGEVITY IN SWITZERLAND: BACKGROUND AND PERSPECTIVES

General and Abdominal Adiposity and Risk of Death in Europe

NCDs POLICY BRIEF - INDIA

Randomized trials versus observational studies

The Prevalence and Determinants of Undiagnosed and Diagnosed Type 2 Diabetes in Middle-Aged Irish Adults

Determinants, Key Players and Possible Interventions

Michael E Dewey 1 and Martin J Prince 1. Lund, September Retirement and depression. Michael E Dewey. Outline. Introduction.

Diabetes. Gojka Roglic. Department of Chronic Diseases and Health Promotion. World Health Organization

MOBILISING THE POTENTIAL OF ACTIVE AGEING IN EUROPE Trends in Healthy Life Expectancy and Health Indicators Among Older People in 27 EU Countries

Hormones and cardiovascular disease, what the Danish Nurse Cohort learned us

UMEÅ INTERNATIONAL SCHOOL

Seniors. health. Report. A Peel Health Status Report

Health and Longevity. Global Trends. Which factors account for most of the health improvements in the 20th century?

Assessing and Forecasting Population Health

The Scottish Health Survey

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

HeartScore Web - based version users guide TABLE OF CONTENTS. 1. Preamble Benefits of using HeartScore Accessing HeartScore...

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)

Preventive Services for Pregnancy SERVICE WHAT IS COVERED INTERVALS OF COVERAGE Anemia Screening Screening Annual screening for pregnant women

The relationship between socioeconomic status and healthy behaviors: A mediational analysis. Jenn Risch Ashley Papoy.

Living a happy, healthy and satisfying life Tineke de Jonge, Christianne Hupkens, Jan-Willem Bruggink, Statistics Netherlands,

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

Women in Europe Towards Healthy Ageing

Body Mass Index as a measure of obesity

Product Development News

Threats and Opportunities the Scientific Challenges of the 21 st Century

Overview of the Adverse Childhood Experiences (ACE) Study. Robert F. Anda, MD, MS Co-Principal Investigator.

CARDIOVASCULAR PROBLEMS IN SURVIVORS OF CHILDHOOD CANCER AND THEIR SIBLINGS

Critical Illness Insurance

Economic recession and alcoholrelated

EMR Nutrition Data Set Indicators: Units of Measurement

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH

Ethnic Minorities, Refugees and Migrant Communities: physical activity and health

Health risk assessment: a standardized framework

Listen to your heart: Good Cardiovascular Health for Life

GRADUATE RESEARCH PROGRAMMES (MSc and PhD) AY2015/2016 MODULE DESCRIPTION

Improving cardiometabolic health in Major Mental Illness

Trend tables. Health Survey for England. A survey carried out on behalf of the Health and Social Care Information Centre. Joint Health Surveys Unit

Smoking in the United States Workforce

Advanced Quantitative Methods for Health Care Professionals PUBH 742 Spring 2015

SECOND M.B. AND SECOND VETERINARY M.B. EXAMINATIONS INTRODUCTION TO THE SCIENTIFIC BASIS OF MEDICINE EXAMINATION. Friday 14 March

49. INFANT MORTALITY RATE. Infant mortality rate is defined as the death of an infant before his or her first birthday.

Quantifying Life expectancy in people with Type 2 diabetes

Culture and experience Health

Diabetes Complications

Q&A on the carcinogenicity of the consumption of red meat and processed meat

Guide to Biostatistics

Healthcare and Population Aging

Preventive Care Guideline for Asymptomatic Elderly Patients Age 65 and Over

Type 1 Diabetes ( Juvenile Diabetes)

Cardiovascular risk assessment: Audit findings from a nurse clinic a quality improvement initiative

ECONOMIC COSTS OF PHYSICAL INACTIVITY

CRITICAL SKILLS FOR OPTIMUM PATIENT CARE: Care Coordination and Health Literacy

HEALTH TRANSITION AND ECONOMIC GROWTH IN SRI LANKA LESSONS OF THE PAST AND EMERGING ISSUES

FACILITATOR/MENTOR GUIDE

Health Profile for St. Louis City

The New Complex Patient. of Diabetes Clinical Programming

University of Michigan Dearborn Graduate Psychology Assessment Program

Analysis of Population Cancer Risk Factors in National Information System SVOD

RR833. The joint effect of asbestos exposure and smoking on the risk of lung cancer mortality for asbestos workers ( )

Mortality Experience in the Elderly in the Impairment Study Capture System

Inhaled Corticosteroids and Diabetes Onset

Underwriting Critical Illness Insurance: A model for coronary heart disease and stroke

HEALTH CARE COSTS 11

Scottish Diabetes Survey Scottish Diabetes Survey Monitoring Group

Transcription:

COMPRESSION OF MORBIDITY: NEW INSIGHTS IN THE ROLE OF LIFESTYLE FACTORS JOHAN MACKENBACH & WILMA NUSSELDER DEPARTMENT OF PUBLIC HEALTH ERASMUS MC

FRIES JF. Aging, natural death, and the compression of morbidity. NEJM 1981 Syllogism: - the human life span is fixed (and average life expectancy is rapidly approaching this limit) - the age at first infirmity will increase - therefore,, the average duration of infirmity will decrease

FRIES (2) Average life expectancy is rapidly approaching its biological limit: - increases in life expectancy reflect mortality declines at younger ages: rectangularization of survival curves - further rectangularization is likely to occur, around mean age at death of 85 years

FRIES (3) Age at first infirmity will increase: - frequency of some chronic illnesses is already declining (e.g. cardiovascular) - further reduction is possible and likely to occur as a result of lifestyle improvement

Life expectancy at birth plateaued in the 1970s, after rapid increases since 1850

OMRAN AR. The epidemiologic transition. Milbank Mem F Q 1971 Pandemics of infection are gradually displaced by degenerative and man-made made diseases, in three stages: - age of pestilence and famine - age of receding pandemics - age of degenerative and man-made made diseases

Historical decline of mortality from infectious disease

and rise of mortality from ischemic heart disease and other chronic diseases

partly due to the rise of cigarette smoking and other lifestyle risk factors

UNANSWERED QUESTIONS Was the epidemiologic transition accompanied historically by an expansion of morbidity (cf. Myers disability transitions )? If so, did higher exposure to modern lifestyle factors historically contribute to an expansion of morbidity? Will reduced exposure to modern lifestyle factors contribute to a compression of morbidity in the future?

OUTLINE OF PRESENTATION Conceptual and empirical progress since Fries 1981 paper Results Dutch research programme on compression of morbidity Conclusions, and implications for research and public health policy

CONCEPTUAL AND EMPIRICAL PROGRESS The remarkable plasticity of human longevity : rapid declines of mortality among the elderly Distinction between morbidity, functional ability, disability, health care use, New methods for quantification of compression: Sullivan, multistate,,. Morbidity and mortality do not change independently

DUTCH RESEARCH PROGRAMME COMPRESSION OF MORBIDITY Collaboration between Erasmus MC and Groningen University Funded by Netherlands Organization for Scientific Research 3 PhD theses (Mamun( Mamun,, Janssen, Franco Duran), 30 papers in international scientific journals

COMPREHENSIVE ANALYSIS DATA AND METHODS (1) Framingham Heart Study, individuals aged 50 and older 3 non-overlapping overlapping 12 year follow-up periods starting 1956-58, 58, 1969-73, and 1985-89 89 Self-reported smoking, time spent on physical activity; measured weight and blood pressure Physician evaluated cardiovascular disease; death 9304 observation intervals used in analysis

COMPREHENSIVE ANALYSIS DATA AND METHODS (2) Pooling of Repeated Observations method Poisson regression, Hazard Ratios for 3 transitions (no CVD to CVD, no CVD to Death, CVD to Death) Confounders selected according to variable of interest (age, sex, education, marital status, comorbidity), start of follow-up period, other cardiovascular risk factors) STATA version 8.2

COMPREHENSIVE ANALYSIS DATA AND METHODS (3) Period multistate life tables, starting at age 50 and closed at age 100, by gender 3 states (free from CVD, history of CVD, death), no backflows By level of exposure to risk factor, transition rates as estimated in Poisson regression Confidence intervals estimated by parametric bootstrapping with @RISK

COMPREHENSIVE ANALYSIS SUMMARY OF RESULTS Smoking and lack of physical activity increase all 3 transition rates -- therefore are neutral w.r.t.. compression Hypertension and obesity primarily increase incidence rates -- therefore lead to expansion of morbidity In the right mix, prevention of these risk factors may produce compression of (cardiovascular) morbidity

Smoking Rate Ratios for 3 transitions 3.00 2.00 1.00 0.00 No CVD to CVD No CVD to Death CVD to Death Never Former Current Corrected for age, sex, hypertension, BMI, physical activity, co(morbidity), start

Smoking Health expectancies from age 50 Effect of Smoking between Age 50 to 80 Free of CVD With CVD 40.0 Number of years 35.0 30.0 25.0 20.0 15.0 10.0 30.0 29.7. 1 7.1 6.1 22.9 23.5 25.8 7.0 18.9 34.8 33.4 6.3 6.2 28.4 27.2 30.6 5.7 24.9 5.0 0.0 Never Former Current Never Former Current Men Smoking status (by sex) Women Source: Our analyses of the Framingham Heart Study

Hypertension Rate Ratios for 3 transitions 3 2 1 0 No CVD to CVD No CVD to Death CVD to Death Normal Pre-hypertension Hypertension Corrected for age, sex, smoking, BMI, physical activity, co(morbidity), start follow-up. Source: Our analyses of the Framingham Heart Study

Hypertension Health expectancies from age 50 Figure 1. Effect of Hypertension at age 50 and over Free of CVD With CVD Number of years 40.0 35.0 30.0 25.0 20.0 15.0 10.0 30.5 3.8 26.8 29.5 6.8 22.7 26.7 7.5 19.2 35.8 3.3 32.5 35.3 6.1 29.2 33.0 7.0 26.0 5.0 0.0 Normal Pre-hypertension Hypertension Normal Pre-hypertension Hypertension Men Hypertension status (by sex) Women Source: Our analyses of the Framingham Heart Study

Physical activity Rate Ratios for 3 transitions 3 2 1 0 No CVD to CVD No CVD to Death CVD to Death High Moderate Low Corrected for age, sex, smoking, co(morbidity), start follow-up. Source:

Physical activity Health expectancies at age 50 Effect of Physical Activity between Age 50 to 80 RRs Number of years 40.0 35.0 30.0 25.0 20.0 15.0 10.0 30.4 7.4 23.0 Free of CVD With CVD 28.2 26.9 7.2 7.1 21.0 19.8 LEs 36.4 6.6 29.7 34.4 32.9 6.6 6.5 27.9 26.5 5.0 0.0 High Moderate Low High Moderate Low Men Level of Physical Activity (by sex) Women Source: Our analyses of the Framingham Heart Study

Overweight Rate Ratios for 3 transitions 3 2 1 0 No CVD to CVD No CVD to Death CVD to Death Normal Overweight Obesity Corrected for age, sex,, smoking, co(morbidity morbidity), start follow-up. Source: Our analyses of the Framingham Heart Study

Overweight Health expectancies from age 50 Figure 1. Effect of overweight between Age 50 to 80 40.0 Free of CVD With CVD 35.0 33.8 34.5 32.7 Number of years 30.0 25.0 20.0 15.0 10.0 28.5 30.5. 0 5.9 7.7 22.2 20.8 26.7 7.8 18.9 5.6 7.4 28.2 27.1 7.6 25.1 5.0 0.0 Normal Overweight Obese Normal Overweight Obese Men BMI status (by sex) Women

COMPREHENSIVE ANALYSIS SUMMARY OF RESULTS Smoking and lack of physical activity increase all 3 transition rates -- therefore are neutral w.r.t.. compression Hypertension and obesity primarily increase incidence rates -- therefore lead to expansion of morbidity In the right mix, prevention of these risk factors may produce compression of (cardiovascular) morbidity

COMPREHENSIVE ANALYSIS LIMITATIONS Uncertainty about internal validity of empirical relationships, e.g. observational study, sampling error, confounding, Uncertainty about external validity of empirical relationships, e.g. only one data-set, only from age 50, only cardiovascular morbidity, Uncertainty of modelling exercise, e.g. no backflows and memory, not dynamic,

CONCLUSIONS (1) It is theoretically possible, but by no means inevitable, to achieve compression of (cardiovascular) morbidity by lifestyle changes It is likely that lifestyle changes have contributed to expansion of (cardiovascular) morbidity during the epidemiologic transition

CONCLUSIONS (2) Fries paper was imprecise in many respects, but probably correct on possibility of compression by lifestyle change Firmer conclusions require strengthening of empirical foundations: pooling observational studies, and doing experimental studies

FURTHER READING Powerpoint presentation will be posted on my personal webpage, where references to published papers can be found too: http://mgzlx4.erasmusmc.nl/ pwp?jpmackenbach